Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy: Opportunity Assessment and Forecast - Update" report has been added to ResearchAndMarkets.com's offering. The SMA market across ...
In November 2025, Epicrispr Biotechnologies Inc. announced a clinical trial is to learn how safe and tolerable EPI-321 is and ...
Emmes today announced that Casimir’s research on the development of the Duchenne Video Assessment (DVA) scorecards was published in PLOS ONE. Emmes acquired Casimir in March 2022, and the group is now ...
"Duchenne Muscular Dystrophy Pipeline Analysis"DelveInsight's, "Duchenne Muscular Dystrophy - Pipeline Insight, 2025,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs ...
A six-year cohort study shows low muscle strength, not sarcopenia, is linked to increased falls risk in patients with ...
– DemonstratedWhole-Body MRI captures heterogeneity and provides key disease severity and progression information correlated with FSHD clinical endpoints – – Demonstrated potential of FSHD-TUG and ...
Understanding individual muscle strength is crucial for optimizing physical therapy and enhancing athletic performance. Traditional methods, however, often fall short in precision. The newly ...
A new study shows that grip strength cannot be used as a proxy for core muscle endurance in axial spondyloarthritis, ...
Muscular endurance tests can help you gauge the effectiveness of your workout and provide clues about your overall physical fitness. When it comes to measuring progress in the weight room, muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback